Politics

Politics By Rachel Cohrs

CMMI’s Fowler on health policy’s ‘stubborn challenges,’ her personal ties to medicine

Exclusive By Lev Facher

Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence

Politics By Rachel Cohrs

‘A slow-moving glacier’: NIH’s sluggish and often opaque efforts to study long Covid draw patient, expert ire

Politics By Nicholas Florko

An ALS therapy sets up a crucial test of the FDA’s independence

Politics By Lev Facher and Damian Garde

The new White House Covid coordinator is great on TV. Is that what America’s pandemic response needs now?

Politics By Nicholas Florko

Lawmakers face off about the future of the FDA’s accelerated approval pathway

Politics By Rachel Cohrs

Medicare premiums could decrease ‘soon,’ after decision on Alzheimer’s drug Aduhelm

Politics By Nicholas Florko

Ashish Jha to replace Jeff Zients as White House Covid response coordinator

Politics By Lev Facher

Biden’s agency to ‘end cancer as we know it’ is finally real. But it has a chaotic road ahead

Politics By Rachel Cohrs and Andrew Joseph

White House begs Congress for Covid funding amid concern about Omicron sister variant

Politics By Nicholas Florko

Three years after the Senate grilled drugmakers … nothing’s changed

Politics By Matthew Herper

In New York appearance, CMS administrator pushes for Congress to act on drug prices

Politics By Rachel Cohrs

‘Haven’t we learned anything?’: Experts warn of disastrous consequences if pandemic funding dries up

Politics By Lev Facher

Nurses, more powerful and visible after Covid, capitalize on new clout in Washington

Politics By Nicholas Florko

Congress moves toward giving FDA authority over synthetic nicotine products like Puff Bar

Politics By Rachel Cohrs

Congress considers a longer phase-out of looser, Covid-era telehealth policies

Politics By Nicholas Florko

Key Democrat moves to crack down on FDA accelerated approvals

Politics By Rachel Cohrs

White House transparency disputes imperil funds to buy Covid therapeutics

Politics By Lev Facher

As Omicron recedes, White House shifts to a more targeted Covid strategy

Politics By Lev Facher

In State of the Union, Biden walks a fine line on Covid optimism

Politics By Nicholas Florko

Pfizer made Trump’s vaccine push harder than it needed to be, former Warp Speed official alleges in new book

Politics By Rachel Cohrs

Federal court strikes down part of HHS surprise billing rule

Politics By Nicholas Florko

FDA asks Congress for more power to regulate certain diagnostic tests, including prenatal screenings

Exclusive By Lev Facher

Inside the culture of fear in Eric Lander’s White House science office

Politics By Darlene Superville — Associated Press

Biden to tap Francis Collins, OSTP deputy to split the role of his ousted science adviser

Politics By Nicholas Florko

6 approval decisions that will make or break Califf’s first year at the FDA

Politics By Nicholas Florko

Senate narrowly confirms Robert Califf to lead the FDA

Politics By Nicholas Florko and Rachel Cohrs

With no votes to spare, Senate advances Califf’s FDA nomination toward final vote

Politics By Lev Facher

Following Lander’s resignation, here’s who might be in line for White House science adviser